Cadrenal Therapeutics Inc (CVKD)
0.51
+0.04
(+9.68%)
USD |
NASDAQ |
May 03, 11:55
Cadrenal Therapeutics 1 Year Total Returns (Daily): -63.81% for May 2, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 02, 2024 | -63.81% |
May 01, 2024 | -67.14% |
April 30, 2024 | -67.16% |
April 29, 2024 | -66.34% |
April 26, 2024 | -70.31% |
April 25, 2024 | -70.59% |
April 24, 2024 | -70.86% |
April 23, 2024 | -74.31% |
April 22, 2024 | -75.46% |
April 19, 2024 | -75.51% |
April 18, 2024 | -72.09% |
April 17, 2024 | -71.39% |
April 16, 2024 | -71.33% |
April 15, 2024 | -70.22% |
April 12, 2024 | -70.73% |
April 11, 2024 | -68.94% |
April 10, 2024 | -70.71% |
April 09, 2024 | -71.62% |
April 08, 2024 | -64.58% |
April 05, 2024 | -57.97% |
April 04, 2024 | -57.18% |
April 03, 2024 | -57.89% |
April 02, 2024 | -56.10% |
April 01, 2024 | -56.10% |
March 28, 2024 | -55.47% |
Date | Value |
---|---|
March 27, 2024 | -50.00% |
March 26, 2024 | -48.11% |
March 25, 2024 | -49.60% |
March 22, 2024 | -46.28% |
March 21, 2024 | -49.60% |
March 20, 2024 | -50.00% |
March 19, 2024 | -60.14% |
March 18, 2024 | -60.84% |
March 15, 2024 | -62.78% |
March 14, 2024 | -61.63% |
March 13, 2024 | -62.19% |
March 12, 2024 | -64.42% |
March 11, 2024 | -60.07% |
March 08, 2024 | -63.21% |
March 07, 2024 | -66.07% |
March 06, 2024 | -67.81% |
March 05, 2024 | -64.14% |
March 04, 2024 | -63.26% |
March 01, 2024 | -62.57% |
February 29, 2024 | -64.62% |
February 28, 2024 | -66.13% |
February 27, 2024 | -70.77% |
February 26, 2024 | -70.23% |
February 23, 2024 | -71.94% |
February 22, 2024 | -67.04% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-75.51%
Minimum
Apr 19 2024
-34.53%
Maximum
Jan 31 2024
-60.63%
Average
-63.23%
Median
1 Year Total Returns (Daily) Benchmarks
Tenax Therapeutics Inc | -84.62% |
Syra Health Corp | -- |
Relmada Therapeutics Inc | 40.38% |
Minerva Neurosciences Inc | -48.80% |
Adverum Biotechnologies Inc | 33.40% |